Neuroprotective Effect of GPE Pretreatment on Rat Hippocampal Organotypic Cultures Exposed to NMDA
Insulin-like growth factor I (IGF-I), a 70 aminoacid-long polypeptide with several metabolic and proliferative actions, is expressed in the rat brain during development and after acute injury [1–3]. The neuroprotective effect of IGF-I has been recently demonstrated in vitro using differentiated PC 12 cells undergoing apoptosis , cerebellar granules cultured in the presence of low K+ concentrations , and primary rat hippocampal neurons . Moreover, there is a growing body of evidence showing that IGF-I injected intracerebroventricularly (icv) is neuroprotective in several experimental models of acute neuronal injury [7–8]. This suggests a possible therapeutic use for this trophic factor in peripheral or central nerve injuries. Some of the biological effects of IGF-I are probably mediated by des(1–3)IGF-I, an IGF-I derivative lacking the N-terminal tripeptide glycine-proline-glutamate (GPE). Des(1–3)IGF-I has been detected in the human brain (among other tissues) and is generally more potent than IGF-I in several in vitro assays [9–12]. The recent observation of Guan et al. that des(l-3)IGF-I is less effective then recombinant human IGF-I (rhIGF-I) as a neuronal rescue agent suggests that the central effects of this growth factor might be partially mediated by the N-terminal tripeptide GPE . GPE (10-5 M) exhibits in vitro mitogenic properties on glial cells , modifies gonadotropin releasing hormone in response to N-methyl-d-aspartate (NMDA) receptor agonists [15–16] and potentiates K+-induced dopamine release from rat striatal slices . All these effects probably involve NMDA receptor-mediated events, since they can be reverted by specific NMDA receptor antagonists.
KeywordsNeuroprotective Effect Organotypic Culture Hippocampal Organotypic Culture Induce Dopamine Release Acute Neuronal Injury
Unable to display preview. Download preview PDF.
- 3.Sandberg Norquist AC, Von Hoist H, Holmin S, Sara VR, Bellander BM, Schalling M (1996) Increase of insulin-like growth factor (IGF)-l, IGF binding protein-2 and -4 mRNAs following cerebral contusion. Brain Res Mol Brain Res 38: 285–293Google Scholar
- 5.DeMello SR, Borodezt K, Soltoff SP (1997) Insulin-like growth factor and potassium depolarisation maintain neuronal survival by distinct pathways: possible involvement of PI3 kinase in IGF-I signalling. J Neurosci 17: 1548–1560Google Scholar
- 6.Lindholm D, Hughes RA, Thoenen H (1995) Multiple neurotrophic factors promote survival of central nervous system neurons. In: Ottoson D, Bartfai T, Hokfelt T, Fuxe K (eds) Challenges and perspectives in neurosciences. Wenner-Gren international series, vol 66. Pergamon, Oxford, pp 141–154Google Scholar
- 8.Johnston BM, Mallard EC Williams CE, Gluckman PD (1996) Insulin like growth factor- 1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 97: 300–8Google Scholar
- 17.Sara VR, Carlson-Skirut C, Bergman T, Jornvall H, Roberts PJ, Crawford M, Nilsson Hakansson L, Civalero I, Nordberg A (1989) Identification of Gly-Pro-Glu (GPE) the aminoterminal of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide. Biochem Biophys Res Commun 165: 766–771PubMedCrossRefGoogle Scholar